These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4392950)

  • 21. The Bureau of Drug Abuse Control: a review of the first two years.
    Gunn JW
    J Forensic Sci; 1968 Jul; 13(3):302-17. PubMed ID: 5757498
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigating clandestine drug laboratories: adverse medical effects in law enforcement personnel.
    Burgess JL; Barnhart S; Checkoway H
    Am J Ind Med; 1996 Oct; 30(4):488-94. PubMed ID: 8892555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dangerous business.
    Fuller K
    Occup Health Saf; 2005 Sep; 74(9):188, 190-1. PubMed ID: 16225016
    [No Abstract]   [Full Text] [Related]  

  • 24. Dangerous drugs: adulterants, diluents, and deception in street samples.
    Johnson DW; Gunn JW
    J Forensic Sci; 1972 Oct; 17(4):629-39. PubMed ID: 4680763
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudoephedrine and methamphetamine and the legal opposition.
    Caldwell GB
    J Okla State Med Assoc; 2012 Feb; 105(2):47. PubMed ID: 22586871
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
    Piscopo JA
    NIDA Res Monogr; 1993; 131():249-59. PubMed ID: 8105384
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring methamphetamine in the United States: A two-decade review as seen by the DEA methamphetamine profiling program.
    Toske SG; McKibben TD
    Drug Test Anal; 2022 Mar; 14(3):416-426. PubMed ID: 34708938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meth labs.
    Goss JF
    JEMS; 1998 Jan; 23(1):50-2, 54, 56 passim. PubMed ID: 10178102
    [No Abstract]   [Full Text] [Related]  

  • 29. Methamphetamine and the changing face of child welfare: practice principles for child welfare workers.
    Connell-Carrick K
    Child Welfare; 2007; 86(3):125-44. PubMed ID: 17722684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent trends in illicit drug trafficking from the Canadian perspective.
    Stamler RT; Fahlman RC; Keele SA
    Bull Narc; 1983; 35(4):23-32. PubMed ID: 6563922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clandestine drug laboratories in Australia and the potential for harm.
    Caldicott DG; Pigou PE; Beattie R; Edwards JW
    Aust N Z J Public Health; 2005 Apr; 29(2):155-62. PubMed ID: 15915620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories--selected states, 1996-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(45):1021-4. PubMed ID: 11098778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The contribution of the L.N.A. (Laboratory of Dutch Pharmacists) to quality control].
    van Pinxteren JA
    Pharm Weekbl; 1968 Apr; 103(17):517-24. PubMed ID: 5665062
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 36. Mice lacking d-amino acid oxidase activity exhibit marked reduction of methamphetamine-induced stereotypy.
    Hashimoto A; Konno R; Yano H; Yoshikawa M; Tamaki R; Matsumoto H; Kobayashi H
    Eur J Pharmacol; 2008 May; 586(1-3):221-5. PubMed ID: 18448092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada.
    Eggertson L
    CMAJ; 2005 Mar; 172(7):865. PubMed ID: 15758187
    [No Abstract]   [Full Text] [Related]  

  • 39. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 40. Children and clandestine drug laboratories: the unseen victims.
    Hawkrigg SL; Winterton PM
    Med J Aust; 2013 Dec; 199(11):739-41. PubMed ID: 24329626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.